1.
Economic Evaluation of FDA-Approved Small Molecule Protein Kinase Inhibitors in Oncology and Non-Oncology Indications in the United States. Ind-Am. J Life. Sci. Biotech. 2023;20(1):15-46. Accessed March 7, 2026. https://iajlb.org/index.php/iajlb/article/view/210